Background: Direct-acting antivirals (DAAs) have altered the prognosis of hepatitis C virus (HCV) disease but its access is limited by socioeconomic factors. Generic DAAs with lower prices were available in Indonesia in 2016. The aim of this study was to determine the efficacy of generic daclatasvir-sofosbuvir. https://awxtfjzwit1x.theisblog.com/35130042/existence-of-three-positive-solutions-to-some-p-laplacian-boundary-value-problems